Entertainment Ave., Suite 410, Boise, ID 83709 Self-Service Billing Support: Disclaimers Content and Consumer Information Disclaimer: This article is an informational product overview and does not constitute medical, health, dietary, financial, or legal advice
F.KelsoG
Choosing drinks that are lower in calories, sugar, and alcohol, yet still festive, can make a big difference in how you feel the next day
This issue highlights key shifts shaping global and Korean markets: The global pharmaceutical markets pivot toward metabolic diseases and the post-GLP-1 competitive era China surpassing the US in new drug approvals, intensifying global biotech competition Rapid growth of Koreas CGM market, alongside continued import dependence Major outcomes from Koreas pan-ministerial medical device R&D program and the launch of its second phase A 1 trillion government investment in medical AI and expanded real-world implementation MFDS regulatory updates, including new drug & biotech guidelines, digital clinical data guidance, updated trial site designations, WHO WLA recognition, and direct government supply of rare medicines Together, these developments signal a more data-driven, innovation-focused, and globally connected clinical and regulatory environment
